These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25398955)

  • 1. Payment for oncolytics in the United States: a history of buy and bill and proposals for reform.
    Polite BN; Ward JC; Cox JV; Morton RF; Hennessy J; Page RD; Conti RM
    J Oncol Pract; 2014 Nov; 10(6):357-62. PubMed ID: 25398955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare Reform: Payment Reform.
    Thomson Reuters Accelus.
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-42. PubMed ID: 29360300
    [No Abstract]   [Full Text] [Related]  

  • 3. Reforming the payment system for medical oncology.
    Bach PB
    JAMA; 2013 Jul; 310(3):261-2. PubMed ID: 23817729
    [No Abstract]   [Full Text] [Related]  

  • 4. The long battle over payment for oncology services in the office setting.
    Bailes JS; Coleman TS
    J Oncol Pract; 2014 Jan; 10(1):1-4. PubMed ID: 24443726
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral oncolytics: Part 2--legislation targeting cost & access, and other initiatives to reduce costs.
    Mancini R; McBride A; Kruczynski M
    Oncology (Williston Park); 2013 Sep; 27(9):865-6, 871. PubMed ID: 24282981
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanding Payment Reform in Medicare: The Cardiology Episode-Based Payment Model.
    Song Z; Blumenthal DM
    JAMA; 2016 Nov; 316(19):1973-1974. PubMed ID: 27838725
    [No Abstract]   [Full Text] [Related]  

  • 7. Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist.
    Polite B; Conti RM; Ward JC
    Am Soc Clin Oncol Educ Book; 2015; ():e75-80. PubMed ID: 25993241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health policy: Putting a price on cancer.
    Sullivan R; Aggarwal A
    Nat Rev Clin Oncol; 2016 Mar; 13(3):137-8. PubMed ID: 26856742
    [No Abstract]   [Full Text] [Related]  

  • 9. Can cancer care lead the way toward a value-based future?
    Macmillan K
    Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP377-SP378. PubMed ID: 31860249
    [No Abstract]   [Full Text] [Related]  

  • 10. Measuring the Value of New Medications and Implications for Medicare's Proposed Part B Drug Payment Model.
    Hwang TJ; LaMattina JL
    JAMA Oncol; 2016 Sep; 2(9):1125-6. PubMed ID: 27388928
    [No Abstract]   [Full Text] [Related]  

  • 11. The Current State of Evidence on Bundled Payments.
    Glickman A; Dinh C; Navathe AS
    LDI Issue Brief; 2018 Oct; 22(3):1-5. PubMed ID: 30300977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare and drug pricing.
    Iglehart JK
    N Engl J Med; 2003 Apr; 348(16):1590-7. PubMed ID: 12700381
    [No Abstract]   [Full Text] [Related]  

  • 13. How to create successful alternative payment models in oncology.
    Miller HD
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP160-SP163. PubMed ID: 28665673
    [No Abstract]   [Full Text] [Related]  

  • 14. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
    Low E;
    J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
    [No Abstract]   [Full Text] [Related]  

  • 15. Mandatory bundled payment model for US cancer patients.
    Das M
    Lancet Oncol; 2018 Dec; 19(12):e677. PubMed ID: 30449659
    [No Abstract]   [Full Text] [Related]  

  • 16. Value-based payment models in oncology: will they help or hinder patient access to new treatments?
    Shah S; Reh G
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP188-SP190. PubMed ID: 28665677
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncology Care Model: Short- and Long-Term Considerations in the Context of Broader Payment Reform.
    Clough JD; Kamal AH
    J Oncol Pract; 2015 Jul; 11(4):319-21. PubMed ID: 26060221
    [No Abstract]   [Full Text] [Related]  

  • 18. Bundling acute and postacute payment: from a culture of compliance to a culture of innovation and best practice.
    DeJong G
    Phys Ther; 2010 May; 90(5):658-62. PubMed ID: 20435610
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential approaches to sustainable, long-lasting payment reform in oncology.
    American Society of Clinical Oncology
    J Oncol Pract; 2014 Jul; 10(4):254-8. PubMed ID: 24737874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing cost-related nonadherence to oral anticancer medications through health policy reform: Challenges and opportunities.
    Jazowski SA; Dusetzina SB
    Cancer; 2020 Aug; 126(16):3613-3616. PubMed ID: 32438468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.